These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9190559)
41. Advances in alternative pharmacotherapy of ADHD. Pityaratstian N J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S357-62. PubMed ID: 16623055 [TBL] [Abstract][Full Text] [Related]
42. Tricyclics for children with cancer. Huessy HR Am J Psychiatry; 1984 Mar; 141(3):472. PubMed ID: 6703124 [No Abstract] [Full Text] [Related]
43. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult. Greydanus DE; Pratt HD; Patel DR Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306 [TBL] [Abstract][Full Text] [Related]
45. Desipramine in the treatment of adolescents with attention deficit disorder. Gastfriend DR; Biederman J; Jellinek MS Am J Psychiatry; 1984 Jul; 141(7):906-8. PubMed ID: 6375400 [TBL] [Abstract][Full Text] [Related]
46. Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia. Al-Haidar FA East Mediterr Health J; 2003; 9(5-6):988-95. PubMed ID: 16450529 [TBL] [Abstract][Full Text] [Related]
47. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults. Waxmonsky JG Essent Psychopharmacol; 2005; 6(5):262-76. PubMed ID: 16222911 [TBL] [Abstract][Full Text] [Related]
48. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested. Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409 [No Abstract] [Full Text] [Related]
49. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents. Wagner KD Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852 [TBL] [Abstract][Full Text] [Related]
50. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder. Poulton A Curr Opin Pediatr; 2006 Aug; 18(4):427-34. PubMed ID: 16914999 [TBL] [Abstract][Full Text] [Related]
51. [Use of amitriptyline in attention deficit hyperactivity disorder]. Guardiola A; Terra AR; Ferreira LT; Londero RG Arq Neuropsiquiatr; 1999 Sep; 57(3A):599-605. PubMed ID: 10667283 [TBL] [Abstract][Full Text] [Related]
52. Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder. Biederman J; Gastfriend D; Jellinek MS; Goldblatt A J Pediatr; 1985 Jun; 106(6):1017-20. PubMed ID: 3998940 [No Abstract] [Full Text] [Related]
53. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
54. Attention deficit hyperactivity disorder. Epidemiologic, pathophysiologic, diagnostic and treatment perspectives. Al-Ghamdy YS; Qureshi NA Saudi Med J; 2001 Aug; 22(8):666-73. PubMed ID: 11573110 [TBL] [Abstract][Full Text] [Related]
55. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder. Kariyawasam SH; Zaw F; Handley SL Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861 [TBL] [Abstract][Full Text] [Related]
58. Attention deficit and hyperactivity disorder: a therapeutic option. Topczewski A Einstein (Sao Paulo); 2014 Sep; 12(3):310-3. PubMed ID: 25295451 [TBL] [Abstract][Full Text] [Related]
59. Early response to desipramine among women with bulimia nervosa. Walsh BT; Sysko R; Parides MK Int J Eat Disord; 2006 Jan; 39(1):72-5. PubMed ID: 16254873 [TBL] [Abstract][Full Text] [Related]
60. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder? Waschbusch DA; Pelham WE; Waxmonsky J; Johnston C J Dev Behav Pediatr; 2009 Apr; 30(2):158-68. PubMed ID: 19363369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]